Publication of Supplementary Prospectus
The following prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Supplementary prospectus dated 16 January 2025 (the "Supplementary Prospectus") supplementing the base prospectus dated 5 April 2024 relating to the Wells Fargo & Company U.S.$50,000,000,000 euro medium term note programme, as supplemented by the supplementary prospectuses dated 7 May 2024, 2 August 2024 and 5 November 2024 (the "Base Prospectus").
To view the full document, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/6361T_1-2025-1-16.pdf
A copy of the Supplementary Prospectus will be submitted to the National Storage Mechanism and will shortly be available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact
Sandra Galvis
Assistant General Counsel, Executive Director and Assistant Secretary
Wells Fargo & Company
sandra.j.galvis@wellsfargo.com
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplementary Prospectus or Base Prospectus (collectively, the "Prospectus") may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.